ramucirumab,pembrolizumab
eli lilly,merck
['sclc', 'nsclc', 'ramucirumab', 'pembrolizumab']
superior survival benefit with ramucirumab plus pembrolizumab observed in ici-resistant nsclc #asco22 #icsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.